69 tracked 13F filers disclose a position in DMRA as of the latest SEC 13F filings, a combined $1.4B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | $234.3M | 9.0M | ▲38× Added · +8.8M sh | Q1 2026 | |
| 2 | Fairmount Funds Management LLC | $226.6M | 8.7M | —Held | Q2 2026 | |
| 3 | Avoro Capital Advisors LLC | $98.4M | 3.8M | —Held | Q2 2026 | |
| 4 | Venrock Adviser, LLC | $93.3M | 3.6M | ▲New +3.6M sh | Q1 2026 | |
| 5 | FCPM III SERVICES B.V. | $63.5M | 2.4M | —Held | Q2 2026 | |
| 6 | RA CAPITAL MANAGEMENT, L.P. | $62.1M | 2.4M | ▲New +2.4M sh | Q1 2026 | |
| 7 | JANUS HENDERSON GROUP PLC | $61.4M | 2.4M | ▲1k× Added · +2.4M sh | Q1 2026 | |
| 8 | VIKING GLOBAL INVESTORS LP | $59.9M | 2.3M | ▲New +2.3M sh | Q1 2026 | |
| 9 | Remedium Capital Partners, LLC | $53.2M | 2.0M | —Held | Q2 2026 | |
| 10 | Commodore Capital LP | $50.2M | 1.9M | ▲New +1.9M sh | Q1 2026 | |
| 11 | BRAIDWELL LP | $42.1M | 1.6M | ▲+81% Added · +726K sh | Q2 2026 | |
| 12 | Bellevue Group AG | $42.1M | 1.6M | ▼−30% Reduced · −679K sh | Q2 2026 | |
| 13 | STATE STREET CORP | $40.2M | 1.5M | ▲+740% Added · +1.4M sh | Q2 2026 | |
| 14 | Cormorant Asset Management, LP | $39.5M | 1.5M | ▲New +1.5M sh | Q1 2026 | |
| 15 | BALYASNY ASSET MANAGEMENT L.P. | $37.5M | 1.4M | ▲New +1.4M sh | Q1 2026 | |
| 16 | PERCEPTIVE ADVISORS LLC | $31.7M | 1.2M | ▲New +1.2M sh | Q1 2026 | |
| 17 | Point72 Asset Management, L.P. | $30.9M | 1.2M | ▲11× Added · +1.1M sh | Q1 2026 | |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | $25.1M | 965K | ▲+300% Added · +724K sh | Q2 2026 | |
| 19 | Siren, L.L.C. | $23.4M | 900K | —Held | Q2 2026 | |
| 20 | Vestal Point Capital, LP | $15.5M | 600K | ▲New +600K sh | Q1 2026 | |
| 21 | Blackstone Inc. | $13.0M | 504K | ▲New +504K sh | Q1 2026 | |
| 22 | MILLENNIUM MANAGEMENT LLC | $12.2M | 472K | ▲New +472K sh | Q1 2026 | |
| 23 | Affinity Asset Advisors, LLC | $11.7M | 450K | ▲New +450K sh | Q1 2026 | |
| 24 | Ikarian Capital, LLC | $8.7M | 336K | ▲+18% Added · +50K sh | Q1 2026 | |
| 25 | Qube Research & Technologies Ltd | $7.3M | 282K | ▲New +282K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 28 funds opened a new position in DMRA and 7 added to an existing one, while 1 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| COGENT BIOSCIENCES INCCOGT | 31 funds | $1.0B |
| DIANTHUS THERAPEUTICS INCDNTH | 29 funds | $912.5M |
| CYTOKINETICS INCCYTK | 29 funds | $875.4M |
| REVOLUTION MEDICINES INCRVMD | 28 funds | $2.2B |
| SPYRE THERAPEUTICS INCSYRE | 28 funds | $1.1B |
| NVIDIA CORPNVDA | 27 funds | $26.4B |
| MICROSOFT CORPMSFT | 27 funds | $16.4B |
| AMAZON.COM INCAMZN | 27 funds | $14.7B |
| ALPHABET INC-CL AGOOGL | 27 funds | $6.5B |
| VERA THERAPEUTICS INCVERA | 27 funds | $534.7M |
| MAZE THERAPEUTICS INCMAZE | 27 funds | $243.0M |
| ELI LILLY & COLLY | 26 funds | $6.5B |
Ranked by how many of DMRA's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 6, 2026 | Winslow Garrett | General Counsel | Sell (S) | 245 | $7K |
Connected entities for DMRA
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/DMRA/capital-change-brief"
Use Arkolith's capital_change_brief for DMRA. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for DMRA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.